Edition:
United States

People: Veracyte Inc (VCYT.OQ)

VCYT.OQ on NASDAQ Stock Exchange Global Market

22.83USD
11:02am EDT
Change (% chg)

$-0.20 (-0.87%)
Prev Close
$23.03
Open
$23.00
Day's High
$23.16
Day's Low
$22.78
Volume
14,568
Avg. Vol
172,626
52-wk High
$26.75
52-wk Low
$5.58

Bishop, John 

Mr. John L. Bishop serves as Lead Independent Director of the Company. He was the Chief Executive Officer and served as a director of Cepheid from April 2002, and became its Chairman of the Board in February 2013. Mr. Bishop retired from Cepheid and resigned from the board of directors following the acquisition of Cepheid by Danaher Corporation in November 2016. Mr. Bishop served as President and a director of Vysis, Inc., a genomic disease management company that was acquired by Abbott Laboratories, from 1993 to 2002, and as Chief Executive Officer from 1996 to 2002. From 1991 until 1993, Mr. Bishop was Chairman and Chief Executive Officer of MicroProbe Corporation, a biotechnology company, and, from 1987 until 1991, of Source Scientific Systems, a biomedical instrument manufacturing company. From 1984 to 1986, Mr. Bishop was President and Chief Operating Officer of Gen-Probe, Inc. From 1968 to 1984, Mr. Bishop held various management positions with American Hospital Supply Company and its affiliates, including a three-year assignment in Japan as an Executive Vice President and Chief Executive Officer of International Reagents Corp., a joint venture between American Hospital Supply Company and Green Cross Corporation. He served as a director of Conceptus, Inc. and a member of its compensation committee until its acquisition by Bayer HealthCare LLC in June 2013 and was previously the chairman of the board of directors of AdvaMedDx, a medical diagnostics industry advocacy group. Mr. Bishop holds a B.S. from the University of Miami.

Basic Compensation

Total Annual Compensation, USD 65,219
Restricted Stock Awards, USD 10,000
Long-Term Incentive Plans, USD --
All Other, USD 38,356
Fiscal Year Total, USD 113,575

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Bonnie Anderson

2,213,130

Christopher Hall

1,084,000

Keith Kennedy

792,685

John Bishop

113,575

Fred Cohen

100,850

Karin Eastham

111,363
As Of  30 Dec 2017